Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Ocugen, Inc. (OCGN) Institutional Ownership & Insider Trading

147 institutions reported holding Ocugen, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 5 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OCGNOcugen, Inc.Follow OCGN — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
250.8M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

147 institutions held 42.8% of the shares. Across filers that reported both quarters, shares held changed +31.2%.

Increased+43New+40Decreased-23Closed-28

Largest moves, shares (millions)

BlackRock+19.7MState Street+11.8MGeode Capital Management+4.6MMarshall Wace-4.6MJane Street Group-3.7MUBS Group AG-2.1M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+11.2Sep 24-8.4Dec 24+5.2Mar 25-24.9Jun 25-6.1Sep 25+15.1Dec 25+45.4Mar 26+34.5Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26147145+31.2%43402328
Mar 26137111+101.5%40382014
Dec 2511061+33.0%31271312
Sep 259846-11.8%19163123
Jun 2510452-32.5%27322437
Mar 2511077+7.3%35142720
Dec 2411472-10.5%30222323
Sep 2411580+22.6%29292114

Ocugen, Inc. — questions

Who owns Ocugen, Inc. stock?
147 institutions reported Ocugen, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.0%), STATE STREET CORP (6.3%), VANGUARD CAPITAL MANAGEMENT LLC (4.2%).
Are Ocugen, Inc. insiders buying or selling?
5 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Ocugen, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.